To date, there is no disease-modifying therapy for Parkinson's disease; however, promising new agents have advanced into clinical trials.
No takes yet. Share an insight, caveat, or question.
Dawson et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: